Skip to main content
. 2024;25(7):2509–2513. doi: 10.31557/APJCP.2024.25.7.2509

Figure 1.

Figure 1

Dose Response Curve of the Anti-Proliferative Aactivity of 4-2-(5-bromo-1H-indol-2-carbonyl)-N-(4-methoxyphenyl) hydrazine-1-carbothioamide against (A) HUVEC cell line; and (B) A549 lung cancer cell line.